SEC Form 4 · accession 0001055726-18-000002
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jong Joseph Kim
Officer — Chief Executive Officer · Director
Period of report
Mar 5, 2018
Accepted (ET)
Mar 7, 2018 · 7:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 5, 2018 | M | 13,333 | — | A | 2,178,533 | D | |
| Common Stock | Mar 5, 2018 | F | 3,711 | $4.29 | D | 2,174,822 | D | |
| Common Stock | holding | — | — | — | 1,750,000 | I | By Family Limited Partnership | |
| Common Stock | holding | — | — | — | 33,563 | I | By Daughter: EK | |
| Common Stock | holding | — | — | — | 33,775 | I | By Son: JK1 | |
| Common Stock | holding | — | — | — | 5,975 | I | By Spouse | |
| Common Stock | holding | — | — | — | 33,533 | I | By Son: JK2 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | — | Mar 5, 2018 | M | 13,333 | D | — | — | Common Stock | 13,333 | 0 | D |
| Common Stock OptionF3 | $4.29 | Mar 5, 2018 | A | 138,250 | A | Mar 5, 2018 | Mar 5, 2028 | Common Stock | 138,250 | 138,250 | D |
| Restricted Stock UnitF4 | — | Mar 5, 2018 | A | 360,300 | A | — | — | Common Stock | 360,300 | 360,300 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 40,000 restricted stock units was as follows: 13,334 shares vested on March 5, 2016; 13,333 shares vested on March 5, 2017; 13,333 shares vested on March 5, 2018. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
- F2The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
- F3The vesting schedule for the 138,250 options is as follows: 34,563 shares vested on March 5, 2018; 34,563 shares will vest on March 5, 2019; 34,562 shares will vest on March 5, 2020; 34,562 shares will vest on March 5, 2021.
- F4Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares will vest on March 5, 2019; 120,100 shares will vest on March 5, 2020; 120,100 shares will vest on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.